Suki Gill

6PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 09, 2025
Evaluating the prognostic value of radiomics and clinical features in metastatic prostate cancer using [68Ga]Ga-PSMA-11 PET/CT.

Kaylee Molin, Nathaniel Barry, Suki Gill

|Jan 03, 2024
Stereotactic body radiotherapy for early-stage lung cancer: a systematic review on the choice of photon energy and linac flattened/unflattened beams.

Ashlesha Gill, Andrew L Hirst, Pejman Rowshanfarzad

|May 14, 2023
Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases.

Shankar Siva, Pitchaya Sakyanun, Tao Mai

|Jun 14, 2022
Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR).

Suki Gill, Anna K Nowak, Samantha Bowyer

|Mar 24, 2022
Randomised controlled trial on the effect of simethicone bowel preparation on rectal variability during image-guided radiation therapy for prostate cancer (SPoRT study).

Jennifer Ward, Suki Gill, Kevin Armstrong

|Mar 11, 2021
In vivo noninvasive preclinical tumor hypoxia imaging methods: a review.

Rebecca A D'Alonzo, Suki Gill, Pejman Rowshanfarzad

Pageof 1

Frequent Collaborators

3 joint publications

Martin A Ebert

2 joint publications

Pejman Rowshanfarzad

2 joint publications

Alistair M Cook

1 joint publications

Rebecca A D'Alonzo